SCHEMBL16245590

SCHEMBL16245590

CC(C)(C)OC(=O)NCCCc1ccc(Nc2ncc3ncn(-c4ccc(OCCCCC(=O)O)cc4)c3n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA3 P51812 4/20 0.50
▸ ITK Q08881 3/20 0.43
▸ AURKA O14965 2/20 0.41
▸ GSK3A P49840 2/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ WEE1 P30291 4/20 0.41
▸ SRC P12931 4/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ BTK Q06187 2/20 0.41
▸ EGFR P00533 3/20 0.40
▸ FGFR1 P11362 1/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ PDGFRA P16234 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CA12 O43570 3/20 0.39
▸ CA1 P00915 3/20 0.39
▸ CA2 P00918 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16245554 0.98 RPS6KA3 (0.51) RPS6KA3ITKAURKAGSK3AGSK3B
SCHEMBL16245539 0.95 ITK (0.47) RPS6KA3ITKAURKAGSK3AGSK3B
SCHEMBL16264888 0.92 ITK (0.48) RPS6KA3ITKAURKAGSK3AGSK3B
SCHEMBL16245605 0.92 RPS6KA3 (0.51) RPS6KA3ITKWEE1SRCJAK3
SCHEMBL16245542 0.89 RPS6KA3 (0.52) RPS6KA3ITKWEE1SRCJAK3
SCHEMBL16245553 0.86 RPS6KA3 (0.45) RPS6KA3ITKSRCJAK3BTK
SCHEMBL16245529 0.85 GSK3A (0.59) ITKAURKAGSK3AGSK3BWEE1
SCHEMBL17827725 0.85 RPS6KA3 (0.56) RPS6KA3AURKAGSK3AGSK3BWEE1
Hydrochloric Acid SCHEMBL16245583 0.84 RPS6KA3 (0.55) RPS6KA3AURKAGSK3AGSK3BWEE1
SCHEMBL16245609 0.84 JAK2 (0.42) RPS6KA3ITKWEE1SRCJAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9861635-B2 Macrocycles as kinase inhibitors MERCK PATENT GMBH (DE) 2018-01-09 — — US disclosed
US-9861635-B2 Macrocycles as kinase inhibitors MERCK PATENT GMBH (DE) 2018-01-09 — — US disclosed
EP-2994471-B1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2017-05-17 — — EP disclosed
EP-2994471-B1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2017-05-17 — — EP disclosed
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2016-06-16 — — US disclosed
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2016-06-16 — — US disclosed
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2016-06-16 — — US disclosed
EP-2994471-A1 MACROCYCLES AS KINASE INHIBITORS Merck Patent GmbH (DE) 2016-03-16 — — EP disclosed
WO-2014180524-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2014-11-13 — — WO disclosed
WO-2014180524-A1 MACROCYCLES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2014-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160166574-A1 MACROCYCLES AS KINASE INHIBITORS EIF2AK4, CDK2, CDK1 RPS6KA3 19/4885ITK 1468/4885AURKA 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback